Hepatic benign and malignant masses in children: a single UK tertiary centre experience

Omar Nasher1, Helen Woodley2, Samah Alizai3

  • 1Department of Paediatric Surgery, The Leeds Teaching Hospitals NHS Trust, Leeds Children's Hospital, Leeds, UK. omar.nasher@nhs.net.

Insights

In a UK tertiary liver unit, most paediatric liver masses were benign (64%), contrary to common belief. Hepatoblastoma was the most frequent malignant liver lesion in children.

Area of Science:

  • Paediatric Hepatology
  • Gastroenterology
  • Oncology

Background:

  • Liver masses in children are rare but require accurate diagnosis.
  • Published literature often suggests a higher prevalence of malignant paediatric liver lesions.

Purpose of the Study:

  • To review the incidence, spectrum, and diagnostic investigations of liver masses in paediatric patients.
  • To compare findings with existing literature on paediatric liver mass prevalence.

Main Methods:

  • Retrospective cohort study of 107 patients (<16 years) at a UK tertiary referral centre (July 2012-July 2019).
  • Data collected on clinical presentation, referral source, investigations (USS, MRI, CT, etc.), and histopathology.
  • Analysis of diagnostic workup and outcomes for paediatric liver masses.

Main Results:

  • 64% of liver masses were benign (haemangioma, hepatic cyst, focal nodular hyperplasia), 36% were malignant.
  • Hepatoblastoma (76%) and hepatocellular carcinoma (8%) were the most common malignant types.
  • Lesions were often detected incidentally (33%) or via palpable mass (29%); 77% were referred from other hospitals.

Conclusions:

  • Contrary to common assumptions, neoplastic (malignant) liver lesions constitute just over one-third of paediatric cases presenting to a tertiary centre.
  • This study highlights the importance of accurate diagnostic pathways for paediatric liver masses, with a significant proportion being benign.
Abstract

Related Concept Videos